Clinical Trial Update: Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV [Phase 2]

View source ↗

Summary

A randomized Phase 2 trial evaluated three therapeutic modalities in patients with stage IIIB/IV non-small cell lung cancer, and the study is reported as comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED